NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic deathElectronic supplementary information (ESI) available: Calculation of the photothermal conversion efficiency. Solution color changes during the synthesis process of GdOF@PDA NPs. Standard curve of R837 in DMSO. Nanoparticle aqueous solution changes during drug release under acidic conditions. Temperature changes in water and GdOF@PDA-HA under laser irradiation (980 nm, 1.5 W). Temperature changes in water and GdOF@PDA-HA under laser irradiation (808 nm, 1.5 W). Temperature changes in water and GdOF@PDA-HA under laser irradiation (1064 nm, 1.5 W). Linear time data versus−ln obtained from the cooling stage. Cell uptake of GdOF@PDA. Confocal microscopy imaging photographs of 4T1 cells cultured with CRT protein antibodies after treating with GdOF@PDA-HA and GdOF@PDA-HA-R837. Confocal microscopy imaging photographs of 4T1 cells cultured with HMGB1 protein antibodies after treating with GdOF@PDA-HA and G

Autor: Wang, Yukun, Li, Wenjing, Lin, Bi, Yuan, Ying, Ning, Pengbo, Tao, Xiaofeng, Lv, Ruichan
Zdroj: Biomaterials Science; 2023, Vol. 11 Issue: 15 p5177-5185, 9p
Abstrakt: Photothermal therapy has a remarkable effect on the destruction of tumors. It kills tumor cells by photothermal ablation and induces immunogenic cell death by activating the immune response in tumor tissues. However, inhibition of the tumor immune microenvironment suppresses PTT-induced body-specific anti-tumor immunity. In this study, we designed the GdOF@PDA-HA-R837-hydrogel complex to achieve NIR-II imaging-guided photothermal ablation and enhanced immune response. Due to the doping of Yb and Er elements and the presence of a polydopamine coating, the synthesized nanoparticles enable NIR-II and photoacoustic imaging of tumor tissues, which will help in the integration of multimodal tumor imaging for diagnosis and treatment. Polydopamine is used as a photothermal agent and drug carrier because of its excellent photothermal ability and high drug loading capacity under 808 nm near infrared light. Hyaluronic acid can bind to specific receptors on the surface of cancer cells, allowing nanoparticles to aggregate around the tumor, thus enhancing the targeting ability of nanoparticles. In addition, imiquimod (R837) has been used as an immune response modulator to enhance the immunotherapeutic effect. The presence of a hydrogel enhanced the retention effect of nanoparticles in the tumor. We demonstrate that the combination of photothermal therapy with immune adjuvants effectively induces ICD, which in turn stimulates the activation of specific anti-tumor immunity and enhances the effect of photothermal therapy in vivo.
Databáze: Supplemental Index